Pituitary volume in psychosis: the first review of the evidence
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
The pituitary gland regulates hypothalamic-pituitary-adrenal (HPA) axis activity by secreting adrenocorticotropic hormone (ACTH), and HPA axis abnormalities have been described in psychosis. Moreover, the pituitary gland secretes prolactin, and some antipsychotics increase the secretion of this hormone. Therefore, it is possible that psychosis is associated with an abnormal volume of the pituitary, as a consequence of a dysfunction in either or both these hormonal systems. The present review of the studies conducted so far clearly indicates that the pituitary is a dynamic organ, which changes differently at different stages of the psychotic disorder, in response to both the disorder itself and the treatment with antipsychotics. Specifically, the pituitary is larger in the months immediately preceding or following the psychosis onset, independently from antipsychotic treatments. However, following this initial enlargement, the pituitary tends to become smaller, as suggested by studies in patients with psychosis of at least two years of duration. On top of these dynamic changes that are linked to the course of the disorder, antipsychotics, and especially antipsychotics inducing hyperprolactinaemia, exert additional enlarging effects on pituitary volume. We suggest that the increased pituitary volume associated with the development of psychosis is due to activation of the hormonal stress response and, specifically, to an increase in the size and number of corticotroph cells producing ACTH, while the increased pituitary volume induced by antipsychotics is linked to the stimulating effects of these drugs on lactotroph cells producing prolactin. Future studies should address these issues that are relevant in improving the care of patients with psychosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The normal, dynamic development of the pituitary appears to be altered, with increased size prior to psychosis onset, and reduced size in chronic psychotic conditions, compared with normal groups [50-53] , although not all studies have reported this [54] .”
From The traumagenic neurodevelopmental model of psychosis revisited (2014) · cites this paper as [51]
Citations
Cites
Raison, C. L., & Miller, A. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1554 · Cited by 1,197 · cited 1×
“In turn, glucocorticoid resistance is a common correlate of stressinduced HPA axis activation in animals and humans (Raison and Miller, 2003).”
BackgroundSchizophrenia: A neural diathesis-stress model.
Walker, E. F., & Diforio, D. (1997) · Psychological Review · doi:10.1037//0033-295x.104.4.667 · Cited by 930
Impaired Fasting Glucose Tolerance in First-Episode, Drug-Naive Patients With Schizophrenia
Ryan, M. C. M., Collins, P., & Thakore, J. H. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.284 · Cited by 828
The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD)
Halbreich, U., Borenstein, J., Pearlstein, T., & Kahn, L. S. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(03)00098-2 · Cited by 740
Emotional Reactivity to Daily Life Stress in Psychosis
Myin-Germeys, I., van Os, J., Schwartz, J. E., Stone, A. A., & Delespaul, P. A. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.12.1137 · Cited by 653 · cited 2×
“…of either an increased susceptibility to daily life stress, an increased level of independent stressors or both (Bebbington et al., 1993; Myin-Germeys et al., 2001): previous studies in acutely psychotic patients found that severity of preadmission stressors is positively correlated…”
ResultModern imaging of the pituitary.
Elster, A. D. (1993) · Radiology · doi:10.1148/radiology.187.1.8451394 · Cited by 322 · cited 2×
“However, the posterior pituitary, which releases vasopressin and oxytocin, comprises less than 20% of the total pituitary volume; moreover, there are no known conditions associated with posterior pituitary enlargement, except tumours (Krishnan et al., 1991; Elster, 1993).”
BackgroundLife Events and Psychosis: Initial Results from the Camberwell Collaborative Psychosis Study
Bebbington, P., Wilkins, S., Jones, P., Foerster, A., Murray, R., Toone, B., & Lewis, S. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.162.1.72 · Cited by 273 · cited 2×
“Alternatively, the increased activation of the stress response could be the consequence of either an increased susceptibility to daily life stress, an increased level of independent stressors or both (Bebbington et al., 1993; Myin-Germeys et al., 2001): previous studies in acutely psychotic patients found that severit…”
ResultPituitary volumes in pediatric maltreatment-related posttraumatic stress disorder
Thomas, L. A., & De Bellis, M. D. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.11.021 · Cited by 266
KRISHNAN, K. R. R., DORAISWAMY, P. M., LURIE, S. N., FIGIEL, G. S., HUSAIN, M. M., BOYKO, O. B., ELLINWOOD, E. H., & NEMEROFF, C. B. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-256 · Cited by 232 · cited 12×
“ACTH, antipsychotic, hypophysis, hypothalamic-pituitary-adrenal(HPA) axis, prolactin, schizophrenia Corresponding author: Carmine M. Pariante, MD, MRCPsych, PhD, Reader, MRC Clinician Scientist Fellow, and Head of the Section and Laboratory of Stress, Psychiatry and Immunology (SPI-Lab), Department of Psychological Me…”
BackgroundInfluentialRyan, M. C. M., Sharifi, N., Condren, R., & Thakore, J. H. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2003.08.011 · Cited by 225 · cited 2×
“…their first psychotic episode have shown increased circulating levels of cortisol and of adrenocorticotropic (ACTH) hormones (Sachar et al., 1970; Ryan et al., 2003, 2004), whereas studies in patients with chronic, established psychosis have found normal HPA axis function, especially if patients…”
BackgroundSaiardi, A., Bozzi, Y., Baik, J.-H., & Borrelli, E. (1997) · Neuron · doi:10.1016/s0896-6273(00)80352-9 · Cited by 204 · cited 3×
“Unfortunately, studies in these populations are complicated by the fact that patients usually receive antipsychotic medication, and some antipsychotics increase prolactin levels in humans and induce proliferation of prolactin-secreting cells in animals (Perez et al., 1986; Saiardi et al., 1997; Halbreich and Kahn, 200…”
BackgroundThe glucocorticoid receptor: part of the solution or part of the problem?
Pariante, C. M. (2006) · Journal of Psychopharmacology · doi:10.1177/1359786806066063 · Cited by 192
Self-citationPariante, C. M., Vassilopoulou, K., Velakoulis, D., Phillips, L., Soulsby, B., Wood, S. J., Brewer, W., Smith, D., Dazzan, P., Yung, A. R., et al. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.185.1.5 · Cited by 180
Self-citationTandon, R., Mazzara, C., DeQuardo, J., Craig, K. A., Meador-Woodruff, J. H., Goldman, R., & Greden, J. F. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90353-n · Cited by 168 · cited 4×
“…cortisol and ACTH levels (Sachar et al., 1970; Ryan et al., 2003, 2004) and non-suppression of cortisol secretion by dexamethasone in the dexamethasone suppression test and in the dexamethasone/corticotropin releasing factor test (Herz et al., 1985; Tandon et al., 1991; Lammers et al., 1995).”
BackgroundInfluentialLammers, C.-H., García-Borreguero, D., Schmider, J., Gotthardt, U., Dettling, M., Holsboer, F., & Heuser, I. J. E. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00065-8 · Cited by 163
Pariante, C. M., Dazzan, P., Danese, A., Morgan, K. D., Brudaglio, F., Morgan, C., Fearon, P., Orr, K., Hutchinson, G., Pantelis, C., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300766 · Cited by 152 · cited 6×
“(Pariante et al., 2005).”
BackgroundSelf-citationHormonal aspects of schizophrenias: an overview
Halbreich, U. M., & Kahn, L. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00124-5 · Cited by 151
Axelson, D., Doraiswamy, P. M., Boyko, O. B., Escalona, P. R., McDonald, W. M., Ritchie, J., Patterson, L. J., Ellinwood, E. H., Nemeroff, C. B., & Krishnan, K. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90070-j · Cited by 150
In Vivo Assessment of Pituitary Gland Volume with Magnetic Resonance Imaging: The Effect of Age*
LURIE, S. N., DORAISWAMY, P. M., HUSAIN, M. M., BOYKO, O. B., ELLINWOOD, E. H., FIGIEL, G. S., & KRISHNAN, K. R. R. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-2-505 · Cited by 148
Decreased pituitary volume in patients with bipolar disorder
Sassi, R. B., Nicoletti, M., Brambilla, P., Harenski, K. A., Mallinger, A. G., Frank, E., Kupfer, D. J., Keshavan, M. S., & Soares, J. C. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01086-1 · Cited by 145
Atypical Antipsychotics and Pituitary Tumors: A Pharmacovigilance Study
Szarfman, A., Tonning, J. M., Levine, J. G., & Doraiswamy, P. M. (2006) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.6.748 · Cited by 145 · cited 1×
“Moreover, the stimulating effects of prolactin-inducing antipsychotics on lactotrophs could partially explain the recent preliminary evidence suggesting an increased risk of developing pituitary tumours in subjects taking prolactin-elevating antipsychotics (Szarfman et al., 2006).”
BackgroundBergemann, N., Mundt, C., Parzer, P., Jannakos, I., Nagl, I., Salbach, B., Klinga, K., Runnebaum, B., & Resch, F. (2004) · Schizophrenia Research · doi:10.1016/j.schres.2004.06.013 · Cited by 120 · cited 4×
“…patients with psychosis (Huber et al., 2001; Warner et al., 2001; Muck-Seler et al., 2004; Segal et al., 2004; Bergemann et al., 2005), and LH and FSH seem to be even reduced in psychotic patients, independently from the effects of antipsychotics (Bergemann et al., 2005; Huber et al., 2001).”
BackgroundResultInfluentialEstradiol levels in psychotic disorders
Huber, T. J., Rollnik, J. D., Wilhelms, J., Mühlen, A. V. Z., Emrich, H. M., & Schneider, U. (2001) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(00)00034-2 · Cited by 103
Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women
Mück‐Šeler, D., Pivac, N., Mustapić, M., Crnčević, Ž., Jakovljević, M., & Šagud, M. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2004.04.001 · Cited by 103 · cited 2×
“…studies have found no evidence that prolactin is elevated in antipsychotic-free patients with psychosis (Huber et al., 2001; Warner et al., 2001; Muck-Seler et al., 2004; Segal et al., 2004; Bergemann et al., 2005), and LH and FSH seem to be even reduced in psychotic patients, independently…”
BackgroundResultDoraiswamy, P. M., Potts, J., Axelson, D., Husain, M. M., Lurie, S. N., Na, C., Escalona, P. R., McDonald, W. M., Figiel, G. S., & Ellinwood, E. H. (1992) · PubMed Central · Cited by 99
Psychoendocrinology of Ego Disintegration
SACHAR, E. J., KANTER, S. S., BUIE, D., ENGLE, R., & MEHLMAN, R. (1970) · American Journal of Psychiatry · doi:10.1176/ajp.126.8.1067 · Cited by 98
MRI study of the pituitary gland in adolescent depression
MacMaster, F. P., & Kusumakar, V. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2003.11.001 · Cited by 85
Doraiswamy, P. M., Krishnan, K. R. R., Figiel, G. S., Husain, M. M., Boyko, O. B., Rockwell, W. J. K., & Ellinwood, E. H. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90628-f · Cited by 68
Development and sexual dimorphism of the pituitary gland
MacMaster, F. P., Keshavan, M., Mirza, Y., Carrey, N., Upadhyaya, A. R., El-Sheikh, R., Buhagiar, C. J., Taormina, S. P., Boyd, C., Lynch, M., et al. (2007) · Life Sciences · doi:10.1016/j.lfs.2006.11.040 · Cited by 63
MacMaster, F. P., El-Sheikh, R., Upadhyaya, A. R., Nutche, J. J., Rosenberg, D. R., & Keshavan, M. S. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.01.022 · Cited by 58
Pituitary Volume in Pediatric Obsessive-Compulsive Disorder
MacMaster, F. P., Russell, A., Mirza, Y., Keshavan, M. S., Banerjee, S. P., Bhandari, R. P., Boyd, C. C., Lynch, M. A., Rose, M., Ivey, J., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.06.028 · Cited by 56
The dexamethasone suppression test in newly hospitalized schizophrenic patients
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.1.127 · Cited by 56
Pérez, R. L., Machiavelli, G. A., Romano, M. I., & Burdman, J. A. (1986) · Journal of Endocrinology · doi:10.1677/joe.0.1080399 · Cited by 53 · cited 2×
“…complicated by the fact that patients usually receive antipsychotic medication, and some antipsychotics increase prolactin levels in humans and induce proliferation of prolactin-secreting cells in animals (Perez et al., 1986; Saiardi et al., 1997; Halbreich and Kahn, 2003) (see Mechanisms below).”
BackgroundPituitary volume in neuroleptic-naïve schizophrenia: A structural MRI study
UPADHYAYA, A., ELSHEIKH, R., MACMASTER, F., DIWADKAR, V, & KESHAVAN, M. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2006.09.033 · Cited by 51
Beresford, T., Arciniegas, D., Rojas, D., Sheeder, J., Teale, P., Aasal, R., Sandberg, E., & Reite, M. (1999) · Journal of Studies on Alcohol · doi:10.15288/jsa.1999.60.586 · Cited by 46 · cited 2×
“post-traumatic stress disorder (Thomas and De, 2004) and subjects with alcohol dependence (Beresford et al., 1999).”
BackgroundSegal, M., Avital, A., Rojas, M., Hausvater, N., Sandbank, S., Liba, D., Moguillansky, L., Tal, I., & Weizman, A. (2004) · Psychiatry Research · doi:10.1016/j.psychres.2004.01.010 · Cited by 42 · cited 2×
“…evidence that prolactin is elevated in antipsychotic-free patients with psychosis (Huber et al., 2001; Warner et al., 2001; Muck-Seler et al., 2004; Segal et al., 2004; Bergemann et al., 2005), and LH and FSH seem to be even reduced in psychotic patients, independently from the effects of…”
BackgroundResultChen, H. H., Nicoletti, M., Sanches, M., Hatch, J. P., Sassi, R. B., Axelson, D., Brambilla, P., Keshavan, M. S., Ryan, N., Birmaher, B., et al. (2004) · Depression and Anxiety · doi:10.1002/da.20044 · Cited by 39
Seasonality and pituitary volume
Schwartz, P. J., Loe, J. A., Bash, C. N., Bove, K. E., Turner, E. H., Frank, J. A., Wehr, T. A., & Rosenthal, N. E. (1997) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(97)00015-2 · Cited by 32 · cited 1×
“It is also important to mention that some studies have found normal pituitary volume in chronic mental disorders, including in children with bipolar disorder (Chen et al., 2004), euthymic patients with major depression (Sassi et al., 2001) and in seasonal depression (Schwartz et al., 1997).”
BackgroundNormal pituitary volumes in chronic schizophrenia
Tournikioti, K., Tansella, M., Perlini, C., Rambaldelli, G., Cerini, R., Versace, A., Andreone, N., Dusi, N., Balestrieri, M., Malagò, R., et al. (2006) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2006.04.004 · Cited by 28 · cited 7×
“Moreover, suggestive evidence of an inverse relationship between duration of illness and pituitary volume has been found in some studies (Tournikioti et al., 2007; Upadhyaya et al., 2007).”
BackgroundResultInfluentialCase report: Pituitary enlargement associated with Addison's disease
Mineura, K., Tsuneo, G. O. T. O., Yoneya, M., Kowada, M., Tamakawa, Y., & Kagaya, H. (1987) · Clinical Radiology · doi:10.1016/s0009-9260(87)80258-1 · Cited by 25 · cited 1×
“Indeed, increased size and number of corticotrophs and increased volume of the pituitary are present also in subjects with a lack of negative inhibitory feedback by circulating glucocorticoid hormones because of Addison’s disease (Mineura et al., 1987).”
BackgroundRecent life stressors and biological markers in newly admitted psychotic patients
Mazure, C. M., Quinlan, D. M., & Bowers, M. B. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00222-3 · Cited by 24
Lower prolactin bioactivity in unmedicated schizophrenic patients
Warner, M. D., Walker, A. M., D’Souza, D. C., Lee, D., Nasseri, D., & Peabody, C. A. (2001) · Psychiatry Research · doi:10.1016/s0165-1781(01)00256-6 · Cited by 18 · cited 1×
“However, previous studies have found no evidence that prolactin is elevated in antipsychotic-free patients with psychosis (Huber et al., 2001; Warner et al., 2001; Muck-Seler et al., 2004; Segal et al., 2004; Bergemann et al., 2005), and LH and FSH seem to be even reduced in psychotic patients,…”
Garner, B., Pariante, C. M., Wood, S. J., Velakoulis, D., Phillips, L., Soulsby, B., Brewer, W. J., Smith, D. J., Dazzan, P., Berger, G. E., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.018 · Cited by 8 · cited 9×
“Specifically, the pituitary volume increases during the prodromal phase leading to psychosis onset (Garner et al., 2005), and it is larger ( 10–20% compared with controls) if assessed during the first two to six months after the psychosis onset (Pariante et al.”
BackgroundResultSelf-citation
Research works printed but not linked: 4
- 1992, AJNR Am J Neuroradiol, 13, 1295
- 2003, Psychoneuroendocrinology, 28, 1
- Lum C., Kucharczyk W., Montanera W., Becker L. (2002) The sella turcica and parasellar region. In Atlas S W (ed.), Magnetic resonance imaging of the brain and spine, third edition. Lippincott Willimas & Wilkins, Philadelphia, pp. 1283-1362
- 10.1037/0033-295X.104.4.667 · DOI · Paper page
Cited by
The dietary pattern of patients with schizophrenia: A systematic review
Dipasquale, S., Pariante, C. M., Dazzan, P., Aguglia, E., McGuire, P., & Mondelli, V. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2012.10.005 · Cited by 394
“…present a higher sensitivity to stress (Myin-Germeys and van Os, 2007), along with hyperactivity of the hypothalamicepituitarye adrenal axis (Pariante, 2008), which in turn causes glucocorticoid resistance (Mondelli et al., 2008; Pariante, 2009) and increased circulating levels of…”
BackgroundSelf-citationPruessner, M., Cullen, A. E., Aas, M., & Walker, E. F. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.013 · Cited by 315
Mondelli, V., Dazzan, P., Hepgul, N., Di Forti, M., Aas, M., D'Albenzio, A., Di Nicola, M., Fisher, H., Handley, R., Marques, T. R., et al. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2009.08.013 · Cited by 278
“One model of psychosis, the vulnerability-stress model, posits that predisposing biological factors increase the sensitivity of some individuals to stress and thus make them more vulnerable to develop psychosis under stressful circumstances (Myin-Germeys and van Os, 2007; Pariante, 2008).”
Self-citationThe traumagenic neurodevelopmental model of psychosis revisited
Read, J., Fosse, R., Moskowitz, A., & Perry, B. (2014) · Neuropsychiatry · doi:10.2217/npy.13.89 · Cited by 262
Epigenetic Mediation of Environmental Influences in Major Psychotic Disorders
Rutten, B. P. F., & Mill, J. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp104 · Cited by 244
Metadata
- Authors
- Pariante, C. M.
- Affiliations
- King's College London (GB)
- Corresponding author
- Pariante, Carmine M.
- ORCID
- Pariante, Carmine M.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2008-03
- Volume
- 22
- Issue
- 2_suppl
- Pages
- 76-81
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W1998842387
- Cited by
- 73
- References
- 43
- Citations by year
- 2026: 1 · 2023: 6 · 2021: 1 · 2020: 5 · 2019: 3 · 2018: 8 · 2017: 2 · 2016: 3 · 2015: 5 · 2014: 7 · 2013: 4 · 2012: 9
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Keywords
- pituitary volume, psychosis, antipsychotic drugs, hyperprolactinemia, prolactin, ACTH, hypothalamic-pituitary-adrenal axis, corticotrophs, lactotrophs, transition to psychosis
- MeSH terms
- Animals, Mental Disorders, Humans, Hyperprolactinemia, Organ Size, Pituitary Gland, Prolactin, Antipsychotic Agents, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.